Novem Group Abbott Laboratories Transaction History
Novem Group
- $686 Billion
- Q4 2024
A detailed history of Novem Group transactions in Abbott Laboratories stock. As of the latest transaction made, Novem Group holds 2,216 shares of ABT stock, worth $292,800. This represents 0.04% of its overall portfolio holdings.
Number of Shares
2,216Holding current value
$292,800% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding ABT
# of Institutions
3,356Shares Held
1.36BCall Options Held
10.6MPut Options Held
8.73M-
Vanguard Group Inc Valley Forge, PA169MShares$22.3 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.3 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.2MShares$10.2 Billion0.35% of portfolio
-
Capital International Investors Los Angeles, CA68MShares$8.98 Billion1.51% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.1MShares$7.15 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $231B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...